We are live on ! Find out more
BAMS

Bellevue Asset Management (Switzerland) Portfolio holdings

AUM $656M
1-Year Est. Return 11.45%
This Fund
S&P 500
This Quarter Est. Return
+10.91%
1 Year Est. Return
+11.45%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$656M
AUM Growth
+$43.2M
Cap. Flow
-$10.7M
Cap. Flow %
-1.63%
Top 10 Hldgs %
31%
Holding
140
New
7
Increased
40
Reduced
26
Closed
13

Top Buys

Rank Stock Value
1
CAH icon
Cardinal Health
CAH
+$7.77M
2
CNC icon
Centene
CNC
+$5.07M
3
LCI
Lannett Company, Inc.
LCI
+$4.41M
4
VTRS icon
Viatris
VTRS
+$4.34M
5
CVS icon
CVS Health
CVS
+$4.04M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$13.6M
2
RDY icon
Dr. Reddy's Laboratories
RDY
+$8.31M
3
KITE
Kite Pharma, Inc.
KITE
+$7.43M
4
THC icon
Tenet Healthcare
THC
+$3.82M
5
ABT icon
Abbott
ABT
+$3.6M

Sector Composition

Rank Sector Weight
1 Healthcare 93.1%
2 Financials 1.62%
3 Industrials 0.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JAZZ icon
26
Jazz Pharmaceuticals
JAZZ
$16.4B
$8.43M 1.29%
60,000
+4,000
+7% +$554K
VRTX icon
27
Vertex Pharmaceuticals
VRTX
$123B
$8.43M 1.28%
67,000
-15,500
-19% -$1.87M
STJ
28
DELISTED
St Jude Medical
STJ
$7.54M 1.15%
122,000
– –
CI icon
29
Cigna
CI
$71.5B
$7.02M 1.07%
48,000
-10,000
-17% -$1.37M
CNC icon
30
Centene
CNC
$33.1B
$6.95M 1.06%
211,260
+171,260
+428% +$5.07M
BMRN icon
31
BioMarin Pharmaceuticals
BMRN
$11.6B
$6.81M 1.04%
65,000
– –
INSY
32
DELISTED
Insys Therapeutics, Inc.
INSY
$6.64M 1.01%
232,000
+22,000
+10% +$610K
COR icon
33
Cencora
COR
$61.7B
$6.64M 1.01%
64,000
+4,000
+7% +$393K
PRGO icon
34
Perrigo
PRGO
$1.84B
$6.37M 0.97%
44,000
+4,000
+10% +$615K
SHPG
35
DELISTED
Shire pic
SHPG
$6.32M 0.96%
30,820
-70
-0.2% -$14.5K
ISRG icon
36
Intuitive Surgical
ISRG
$133B
$6.31M 0.96%
103,950
-18,000
-15% -$1.01M
CHRS icon
37
Coherus Oncology
CHRS
$224M
$5.9M 0.9%
257,000
+27,000
+12% +$695K
AET
38
DELISTED
Aetna Inc
AET
$5.73M 0.87%
53,000
– –
HALO icon
39
Halozyme
HALO
$9.91B
$5.51M 0.84%
318,000
+72,000
+29% +$1.15M
EW icon
40
Edwards Lifesciences
EW
$51.2B
$5.45M 0.83%
207,000
-60,000
-22% -$1.56M
HUM icon
41
Humana
HUM
$43.7B
$5.36M 0.82%
30,000
– –
HZNP
42
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$5.31M 0.81%
245,000
+25,000
+11% +$487K
ALKS icon
43
Alkermes
ALKS
$8.32B
$5.2M 0.79%
65,500
+6,500
+11% +$455K
JNJ icon
44
Johnson & Johnson
JNJ
$621B
$5.14M 0.78%
50,000
– –
BCR
45
DELISTED
CR Bard Inc.
BCR
$5.12M 0.78%
27,000
+2,500
+10% +$468K
MNK
46
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$5.08M 0.77%
68,000
-12,000
-15% -$808K
XENT
47
DELISTED
Intersect ENT, Inc
XENT
$5.06M 0.77%
225,000
+25,223
+13% +$499K
EGBN icon
48
Eagle Bancorp
EGBN
$861M
$4.88M 0.74%
+55,000
New +$2.76M
SUPN icon
49
Supernus Pharmaceuticals
SUPN
$2.73B
$4.77M 0.73%
355,000
+35,000
+11% +$541K
CYH icon
50
Community Health Systems
CYH
$416M
$4.63M 0.71%
211,072
+14,641
+7% +$378K
1
2
3 4 5

Similar funds

VFAM
Valley Forge Asset Management King Of Prussia, Pennsylvania $645M AUM 5.8% 1-Year Est. Return
MSU
Maple Securities USA Jersey City, New Jersey $672M AUM 1.03% 1-Year Est. Return
PSI
Pinnacle Summer Investments Fairfax, Virginia $678M AUM 9.54% 1-Year Est. Return
SFP
Santa Fe Partners Santa Fe, New Mexico $608M AUM 8.76% 1-Year Est. Return
MCM
Mazama Capital Management Portland, Oregon $544M AUM 9.52% 1-Year Est. Return
NMIS
Northwestern Mutual Investment Services Milwaukee, Wisconsin $525M AUM 2.45% 1-Year Est. Return
SM
Stratton Management King Of Prussia, Pennsylvania $824M AUM 1.55% 1-Year Est. Return
ZAM
Zenit Asset Management Stockholm, Sweden $450M AUM 8.32% 1-Year Est. Return

Bellevue Asset Management (Switzerland)'s Q4 2015 Portfolio in Review

As of Q4 2015, Bellevue Asset Management (Switzerland) held 140 positions worth $656M, up 7% from $613M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Bellevue Asset Management (Switzerland)'s Q4 2015 filing shows 7 new, 40 increased, 26 reduced and 13 closed positions. Its largest new stake was Lannett Company, Inc.: 26,870 shares worth $4.31M. The largest sale was Allergan plc, an estimated $13.6M.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, up from 92% a quarter earlier, followed by Financials and Industrials.

  • Bellevue Asset Management (Switzerland)'s largest Q4 2015 buy was Lannett Company, Inc.: 26,870 shares worth $4.31M.
  • Bellevue Asset Management (Switzerland) added most to Cardinal Health in Q4 2015, an estimated $7.77M increase.
  • Bellevue Asset Management (Switzerland)'s biggest Q4 2015 reduction was Kite Pharma, Inc., cutting an estimated $7.43M.
  • Bellevue Asset Management (Switzerland) fully exited Allergan plc in Q4 2015, selling an estimated $13.6M.
  • Bellevue Asset Management (Switzerland)'s ten largest holdings make up 31% of its $656M portfolio in Q4 2015.
  • Bellevue Asset Management (Switzerland) opened 7 new positions and closed 13 in Q4 2015.
  • Bellevue Asset Management (Switzerland)'s portfolio value rose 7% quarter-over-quarter to $656M.

Based on Bellevue Asset Management (Switzerland)'s 13F filing for Q4 2015, filed 12 Feb 2016.